Active Recombinant Human B4GALT1 Protein (AA 63-398), N-6×His/GFP tagged

• Cat.No.: B4GALT1-21H
• Product Overview: Recombinant Human B4GALT1 Protein (AA 63-398) with N-6×His/GFP tag was expressed in HEK293.

Specification

• Description: This gene is one of seven beta-1,4-galactosyltransferase (beta4GalT) genes. They encode type II membrane-bound glycoproteins that appear to have exclusive specificity for the donor substrate UDP-galactose; all transfer galactose in a beta1,4 linkage to similar acceptor sugars: GlcNAc, Glc, and Xyl. Each beta4GalT has a distinct function in the biosynthesis of different glycoconjugates and saccharide structures. As type II membrane proteins, they have an N-terminal hydrophobic signal sequence that directs the protein to the Golgi apparatus and which then remains uncleaved to function as a transmembrane anchor. By sequence similarity, the beta4GalTs form four groups: beta4GalT1 and beta4GalT2, beta4GalT3 and beta4GalT4, beta4GalT5 and beta4GalT6, and beta4GalT7. This gene is unique among the beta4GalT genes because it encodes an enzyme that participates both in glycoconjugate and lactose biosynthesis. For the first activity, the enzyme adds galactose to N-acetylglucosamine residues that are either monosaccharides or the nonreducing ends of glycoprotein carbohydrate chains. The second activity is restricted to lactating mammary tissues where the enzyme forms a heterodimer with alpha-lactalbumin to catalyze UDP-galactose + D-glucose <=> UDP + lactose. The two enzymatic forms result from alternate transcription initiation sites and post-translational processing. Two transcripts, which differ only at the 5' end, with approximate lengths of 4.1 kb and 3.9 kb encode the same protein. The longer transcript encodes the type II membrane-bound, trans-Golgi resident protein involved in glycoconjugate biosynthesis. The shorter transcript encodes a protein which is cleaved to form the soluble lactose synthase.
• Source: HEK293
• Species: Human
• Tag: His&GFP
• Bio-activity: ≥0.8 μmol/min/mg
• Molecular Mass: ~65-70 kDa
• Protein length: AA 63-398
• AA Sequence: GSNSAAAIGQSSGELRTGGARPPPP LGASSQPRPGGDSSPVVDSGPGPAS NLTSVPVPHTTALSLPACPEESPLL VGPMLIEFNMPVDLELVAKQNPNVK MGGRYAPRDCVSPHKVAIIIPFRNR QEHLKYWLYYLHPVLQRQQLDYGIY VINQAGDTIFNRAKLLNVGFQEALK DYDYTCFVFSDVDLIPMNDHNAYRC FSQPRHISVAMDKFGFSLPYVQYFG GVSALSKQQFLTINGFPNNYWGWGG EDDDIFNRLVFRGMSISRPNAVVGR CRMIRHSRDKKNEPNPQRFDRIAHT KETMLSDGLNSLTYQVLDVQRYPLY TQITVDIGTPS
• Purity: >95%, by SDS-PAGE under reducing conditions and visualized by Coomassie Blue stain.
• Stability: 6 months if stored at -80 centigrade. Avoid repeated freeze thaws.
• Concentration: 1 mg/mL
• Storage Buffer: Supplied as a 0.2 μm filtered solution in 20mM HEPES pH 7.0 and 100mM NaCl buffer, with 10% Glycerol.
• Preservative: 0.05 % NaN3
• Shipping: This product is shipped as 0.2μm filtered product on dry ice.

Gene Information

• Gene Name: B4GALT1 UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 [ Homo sapiens (human) ]
• Official Symbol: B4GALT1
• Synonyms: B4GALT1; UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1; GGTB2; beta-1,4-galactosyltransferase 1; beta4Gal T1; lactose synthase; beta-1,4-GalTase 1; glycoprotein-4-beta-galactosyltransferase 2; UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1; UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1; GT1; GTB; CDG2D; B4GAL-T1; beta4Gal-T1; MGC50983; DKFZp686N19253
• Gene ID: 2683
• mRNA Refseq: NM_001497
• Protein Refseq: NP_001488
• MIM: 137060
• UniProt ID: P15291

Reviews

10/14/2021

Quick shipping, excellent quality.

10/03/2021

High quality, excellent performance.

05/16/2021

Reliable, good for research.

Q&As

How does B4GALT1 contribute to the synthesis of glycoproteins and glycolipids?

It synthesizes lactosylceramide, a building block for complex glycosphingolipids in glycoprotein and glycolipid synthesis.

What is the primary function of B4GALT1 in cellular processes?

B4GALT1 is crucial for glycosylation, attaching galactose to proteins and lipids.

In which cells or tissues is B4GALT1 predominantly expressed?

B4GALT1 is widely expressed but has higher activity in the liver, kidney, and intestine.

What therapeutic strategies are being explored targeting B4GALT1 for disease treatment?

Therapeutic strategies include targeting B4GALT1 to modulate its activity in cancer and other diseases.

How is B4GALT1 implicated in cancer progression and metastasis?

Altered B4GALT1 expression is linked to cancer, influencing tumor growth and metastasis.

Are there known genetic mutations in B4GALT1 associated with specific diseases or conditions?

Genetic mutations in B4GALT1 are associated with some rare metabolic disorders.

What role does B4GALT1 play in immune system function?

It modulates immune responses by altering glycosylation patterns on immune cells.